NOVOS careers

NOVOS is a breakthrough Longevity nutraceutical supplement brand, that helps people live healthier, longer lives. We offer science and evidence-based longevity supplements that have been formulated by the worlds' most esteemed longevity scientists, and are the first to address all hallmarks of aging. We will soon offer medical grade, at-home aging tests, and give back to the scientific community as part of our mission as a Public Benefit Corporation.

Our Scientific Advisors & SAB is composed of:

- Dr. George Church PhD (Harvard & MIT professor, inventor of first gene sequencing method)
- Dr. J Pedro Magalhaes PhD (longevity scientist at University of Liverpool, Harvard postdoc, TED speaker)
- Dr. Matt Kaeberlein PhD (U of Washington longevity scientist, rapamycin authority, MIT postdoc)
- Dr. Pamela Maher (The Salk Institute researcher, U of British Columbia postoc)
- Dr. Avi Rosenbaum PhD (Harvard Postdoc, geneticist)
- Dr. Oliver Medvedik (geneticist, longevity scientist, Harvard postdoc).

We have introduced two science-based formulations to date, with additional clinical trials and in vitro human studies underway.

NOVOS raised $3.15MM in late 2021 from some of the leading investors in the Longevity industry, and we are scaling rapidly.